Jacobs Levy Equity Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-19,357
| Closed | -$518K | – | 1069 |
|
|
2023
Q4 | $518K | Sell |
19,357
-20,757
| -52% | -$555K | ﹤0.01% | 822 |
|
|
2023
Q3 | $2.43M | Buy |
40,114
+11,701
| +41% | +$708K | 0.01% | 531 |
|
|
2023
Q2 | $2.89M | Buy |
+28,413
| New | +$2.89M | 0.02% | 501 |
|
|
2022
Q2 | – | Sell |
-25,507
| Closed | -$11.2M | – | 1106 |
|
|
2022
Q1 | $11.2M | Sell |
25,507
-201
| -0.8% | -$87.9K | 0.08% | 275 |
|
|
2021
Q4 | $11.3M | Buy |
25,708
+960
| +4% | +$421K | 0.08% | 277 |
|
|
2021
Q3 | $13.8M | Buy |
24,748
+15,035
| +155% | +$8.36M | 0.09% | 247 |
|
|
2021
Q2 | $4.99M | Sell |
9,713
-7,212
| -43% | -$3.71M | 0.03% | 429 |
|
|
2021
Q1 | $13.2M | Buy |
16,925
+2,689
| +19% | +$2.1M | 0.1% | 236 |
|
|
2020
Q4 | $7.75M | Buy |
14,236
+3,548
| +33% | +$1.93M | 0.07% | 309 |
|
|
2020
Q3 | $4.9M | Buy |
10,688
+9,291
| +665% | +$4.26M | 0.05% | 348 |
|
|
2020
Q2 | $860K | Buy |
+1,397
| New | +$860K | 0.01% | 700 |
|
|
2016
Q3 | – | Sell |
-364
| Closed | -$63K | – | 1148 |
|
|
2016
Q2 | $63K | Sell |
364
-136
| -27% | -$23.5K | ﹤0.01% | 1119 |
|
|
2016
Q1 | $112K | Buy |
+500
| New | +$112K | ﹤0.01% | 1026 |
|